Featured

Status

Health Topics

Any Category
Diseases
Nutritional and Metabolic Diseases
Metabolic Diseases
Clear Filters

Search Clinical Trials

53 Results
Recruiting
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
The aim now is to perform a large, prospective trial to test Twizzlers® as a cost effective glucola alternative in a gravid population to determine its sensitivity, specificity, PPV (positive …
Baylor Role: Lead Sponsor
Completed
Lifestyle Intervention for Senior Diabetics
Background: Hypothesis: Lifestyle intervention will be highly successful in the population of older adults with diabetes, with resultant significant improvement in glycemic metabolic control mediated by improved insulin action/secretion, accompanied …
Baylor Role: Lead Sponsor
Completed
Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based Intervention
The purpose of this study is to pilot test a newly developed strengths-based clinical intervention delivered by diabetes care providers in the context of routine ambulatory diabetes care, designed to …
Baylor Role: Lead Sponsor
Completed
Video Games for Obesity and Diabetes Prevention-Diab & Nano
This project is to conduct an efficacy trial of Diab and Nanoswarm to assess their potential for minimizing T2D and obesity risks. The proposed research will be conducted in two …
Baylor Role: Lead Sponsor
Completed
Optimizing Self-Management Adherence and Glycemic Control in Older Teens With Type 1 Diabetes: The Teenwork Study
Glycemic control deteriorates during adolescence as parents become less involved in teens' diabetes management and adherence declines. Thus, there is a need to improve adherence and glycemic control in mid …
Baylor Role: Collaborator
Completed
A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
- The study will include a total of 4 visits. The time period between the very first visit and the very last visit will be between 10 and 15 weeks. …
Baylor Role: Lead Sponsor
Terminated
Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
Obese, insulin resistant individuals have an excess of fat in the liver which is not attributable to alcohol or other known causes of liver disease, a condition defined as nonalcoholic …
Baylor Role: Lead Sponsor
Completed
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
The target fasting serum glucose (FSG) and pre-meal SG was 90-140 mg/dL, and the random SG was less than 180 mg/dL, taking into consideration the ADA/AACE target glucose levels in …
Baylor Role: Lead Sponsor
Completed
Effect of Exenatide on Liver and Heart Fat and Inflammation
Type 2 diabetics and insulin resistant individuals have an excess of fat in the liver which is not attributable to alcohol or other known causes of liver disease, a condition …
Baylor Role: Lead Sponsor
Completed
Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
Type-2 diabetes mellitus is a public health concern. According to the World health organization (WHO), diabetes mellitus affects more than 180 million people worldwide. Type 2 diabetes mellitus accounts for …
Baylor Role: Lead Sponsor